Showing results (941-950 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|April 15, 2024
YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistanceJian Yang, Yawen Chen, Yang He, et al.
Drug Development Research|January 15, 2026
Exploring CPP Enhanced Hypoxia Targeting: An Approach Using Radiolabeled 2-nitroimidazole TAT ConjugateSweety Mittal, Akanksha Jain, Ashwini Babu, et al.
Drug Development Research|January 13, 2026
Desmopressin Induces Mitochondrial Fragmentation and Dysfunction in Human U87 MG Glioma Cells via CaMKII-Drp1 Signaling PathwaySitao Liang, Yonghua Zhu, Jiahao Su, et al.
Drug Development Research|January 19, 2026
Targeting of PCSK9 in the Management of Alzheimer's Disease: Expanding the New Potential Key PlayerMansour Alanazi, Hayder M Al-Kuraishy, Nawar R Hussain, et al.
Drug Development Research|January 28, 2026
Reprogramming the Tumor Microenvironment: Calebin A as a Polyphenolic Paradigm Shift in Controlling Inflammation, Stemness, and Resistance in Colorectal CancerAbdullah A Alshehri, Wael Y Khawagi
Drug Development Research|February 3, 2026
Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic InnovationMohammad Javad Mehran, Sara Mohammadzadeh, Mansoor Bolideei, et al.
Drug Development Research|February 2, 2026
Halting Tuberculosis in Its Tracks: Advances and Strategies for Discovering Therapeutic Targets in Mycobacterium tuberculosisAyushi Sharma, Gyanendra Singh, Rahul Shrivastava
Drug Development Research|November 23, 2025
Screening Natural Phenolic Compounds for Blood-Brain Barrier Permeability, Alongside GSK-3β, CK-1δ, and AChE Inhibition, for the Treatment of Alzheimer's DiseasePerihan Gürbüz, Şengül Dilem Doğan, Miyase Gözde Gündüz, et al.
Drug Development Research|November 17, 2025
Leveraging the Fragment Merging Approach for Synthetizing Novel Selanyl Phenyl Acetamide Thiazolidinedione Hybrids Endowed With Apoptotic Potential for Cancer TreatmentSaad Shaaban, Ayman Abo Elmaaty, Aya Yaseen Mahmood Alabdali, et al.
Drug Development Research|December 18, 2024
Exosome-Shuttled METTL14 From AML-Derived Mesenchymal Stem Cells Promotes the Proliferation and Radioresistance in AML Cells by Stabilizing ROCK1 Expression via an m6A-IGF2BP3-Dependent MechanismCheng Wang, Rui Song, Jinjin Yuan, et al.
Pageof 138